Ulcerative colitis during CTLA-4Ig therapy in a patient with rheumatoid arthritis [20]

Gut

Volumn 55, Issue 7, 2006, Pages 1059-1060

  Amezcua Guerra, L M ^a   Hernandez Martinez B ^a   Pineda, C ^a   Bojalil, R ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; AZATHIOPRINE; B7 ANTIGEN; CD86 ANTIGEN; HYDROXYCHLOROQUINE; LEFLUNOMIDE; MESALAZINE; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE;

ABDOMINAL PAIN; ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; DIARRHEA; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECTUM HEMORRHAGE; RHEUMATOID ARTHRITIS; SEROLOGY; T LYMPHOCYTE; TENESMUS; TREATMENT RESPONSE; ULCERATIVE COLITIS; WEIGHT REDUCTION;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COLITIS, ULCERATIVE; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOCONJUGATES; MALE; METHOTREXATE; MIDDLE AGED;

EID: 33745481074     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.095539     Document Type: Letter

References (10)

1. Sugisaki K, Honma F, Iwadate H, et al. Ulcerative colitis occurring in the course of rheumatoid arthritis: a case successfully treated with mesalamine enema. Intern Med 2004;43:1046-50.
2. Adachi Y, Hinoda Y, Takahashi H, et al. Rheumatoid arthritis associated with ulcerative colitis. J Gastroenterol 1996;31:590-5.
3. Boyer F, Fontanges E, Miossec P. Rheumatoid arthritis associated with ulcerative colitis: a case with severe flare of both diseases after delivery. Ann Rheum Dis 2001;60:901.
4. Aydin Y, Ozcakar L, Yildiz M, et al. Liaison between rheumatoid arthritis and ulcerative colitis. Rheumatol Int 2003;23:47-8.
5. Stephens MD. The diagnosis of adverse medical events associated with drug treatment. Adverse Drug React Acute Poisoning Rev 1987;6:1-35.
6. Miller FW, Hess EV, Clauw DJ, et al. Approaches for identifying and defining environmentally associated rheumatic disorders. Arthritis Rheum 2000;43:243-9.
7. Kremer JM, Westhovens R, Leon M, et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 2003;349:1907-15.
8. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family Revisited. Annu Rev Immunol 2005;23:515-48.
9. Masteller EL, Chuang E, Mullen AC, et al. Structural analysis of CTLA-4 function in vivo. J Immunol 2000;164:5319-27.
10. Heller F, Florian P, Bojarski C, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005;129:550-64.